Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glyburide Glycemic Profile in Gestational Diabetes
NCT01947699Phase 4Withdrawn
- Sponsor
- University of Pittsburgh
- Start
- Sep 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glibenclamide in gestational diabetes mellitus (GDM), sponsored by University of Pittsburgh. Planned start Sep 2013; status: withdrawn.
02
Drugs
glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01947699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01947699.